Can a dry eye drug soothe glaucoma Patients' aching eyes?
NCT ID NCT04354545
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether Xiidra, an FDA-approved eye drop for dry eye, can reduce eye discomfort and dryness in people with glaucoma who are already using multiple eye drops to control eye pressure. About 75 participants will receive Xiidra as part of their standard care and be followed for 12 weeks. The goal is to see if their eye surface health and comfort improve.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Doheny Eye Center UCLA
RECRUITINGFountain Valley, California, 92708, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Could your personality predict glaucoma drug side effects?
- Could a single eye implant replace years of glaucoma drops?